Hodgkin Lymphoma, Version 2.2022 Featured Updates to the NCCN Guidelines

被引：39

作者：

Hoppe, Richard T. ^{[1
]}

Advani, Ranjana H. ^{[1
]}

Ai, Weiyun Z. ^{[2
]}

Ambinder, Richard F. ^{[3
]}

Armand, Philippe ^{[4
]}

Bello, Celeste M. ^{[5
]}

Benitez, Cecil M. ^{[6
]}

Chen, Weina ^{[7
]}

Dabaja, Bouthaina ^{[8
]}

Daly, Megan E. ^{[9
]}

Gordon, Leo I. ^{[10
]}

Hansen, Neil ^{[11
]}

Herrera, Alex F. ^{[12
]}

Hochberg, Ephraim P. ^{[13
]}

Johnston, Patrick B. ^{[14
]}

Kaminski, Mark S. ^{[15
]}

Kelsey, Christopher R. ^{[16
]}

Kenkre, Vaishalee P. ^{[17
]}

Khan, Nadia ^{[18
]}

Lynch, Ryan C. ^{[19
]}

Maddocks, Kami ^{[20
,21
]}

McConathy, Jonathan ^{[22
]}

Metzger, Monika ^{[23
]}

Morgan, David ^{[24
]}

Mulroney, Carolyn ^{[25
]}

Pullarkat, Sheeja T. ^{[5
]}

Rabinovitch, Rachel ^{[26
]}

Rosenspire, Karen C. ^{[27
]}

Seropian, Stuart ^{[28
]}

Tao, Randa ^{[29
]}

Torka, Pallawi ^{[30
]}

Winter, Jane N.

Yahalom, Joachim ^{[31
]}

Yang, Joanna C. ^{[32
,33
]}

Burns, Jennifer L. ^{[34
]}

Campbell, Mallory ^{[34
]}

Sundar, Hema ^{[34
]}

机构：

[1] Stanford Canc Inst, Stanford, CA 94305 USA

[2] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[3] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[4] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[7] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[9] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA USA

[10] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[11] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[12] City Hope Natl Med Ctr, Duarte, CA USA

[13] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[14] Mayo Clin, Canc Ctr, Rochester, MN USA

[15] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[16] Duke Canc Inst, Durham, NC USA

[17] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[18] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[19] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[20] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[21] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

[22] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[23] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[24] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[25] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

[26] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[27] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[28] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[29] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[30] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[31] Mem Sloan Kettering Canc Ctr, New York, NY USA

[32] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[33] Washington Univ, Sch Med, St Louis, MO 14263 USA

[34] Natl Comprehens Canc Network, Ft Washington, MD USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 04期

关键词：

STEM-CELL TRANSPLANTATION; INTENSITY-MODULATED RADIOTHERAPY; MEDIASTINAL RADIATION-THERAPY; INVOLVED-NODE RADIOTHERAPY; BRENTUXIMAB VEDOTIN; PHASE-II; SINGLE-ARM; OPEN-LABEL; FOLLOW-UP; DISEASE;

D O I：

10.6004/jnccn.2022.0021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hodgkin lymphoma (HL) is an uncommon malignancy of B-cell origin. Classical HL (cHL) and nodular lymphocyte-predominant HL are the 2 main types of HL. The cure rates for HL have increased so markedly with the advent of modern treatment options that overriding treatment considerations often relate to long-term toxicity. These NCCN Guidelines Insights discuss the recent updates to the NCCN Guidelines for HL focusing on (1) radiation therapy dose constraints in the management of patients with HL, and (2) the management of advanced-stage and relapsed or refractory cHL.

引用

页码：323 / 334

页数：12

共 50 条

[1] Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines
Flaig, Thomas W.
Spiess, Philippe E.
Abern, Michael
Agarwal, Neeraj
Bangs, Rick
Boorjian, Stephen A.
Buyyounouski, Mark K.
Chan, Kevin
Chang, Sam
Friedlander, Terence
Greenberg, Richard E.
Guru, Khurshid A.
Herr, Harry W.
Hoffman-Censits, Jean
Kishan, Amar
Kundu, Shilajit
Lele, Subodh M.
Mamtani, Ronac
Margulis, Vitaly
Mian, Omar Y.
Michalski, Jeff
Montgomery, Jeffrey S.
Nandagopal, Lakshminarayanan
Pagliaro, Lance C.
Parikh, Mamta
Patterson, Anthony
Plimack, Elizabeth R.
Pohar, Kamal S.
Preston, Mark A.
Richards, Kyle
Sexton, Wade J.
Siefker-Radtke, Arlene O.
Tollefson, Matthew
Tward, Jonathan
Wright, Jonathan L.
Dwyer, Mary A.
Cassara, Carly J.
Gurski, Lisa A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (08): : 866 - 878
[2] Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Hoppe, Richard T.
Advani, Ranjana H.
Ai, Weiyun Z.
Ambinder, Richard F.
Aoun, Patricia
Bello, Celeste M.
Bierman, Philip J.
Blum, Kristie A.
Chen, Robert
Dabaja, Bouthaina
Duron, Ysabel
Forero, Andres
Gordon, Leo I.
Hernandez-Ilizaliturri, Francisco J.
Hochberg, Ephraim P.
Maloney, David G.
Mansur, David
Mauch, Peter M.
Metzger, Monika
Moore, Joseph O.
Morgan, David
Moskowitz, Craig H.
Poppe, Matthew
Pro, Barbara
Winter, Jane N.
Yahalom, Joachim
Sundar, Hema
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (05): : 589 - 597
[3] NCCN Guidelines® Insights Hodgkin Lymphoma, Version 1.2018 Featured Updates to the NCCN Guidelines
Hoppe, Richard T.
Advani, Ranjana H.
Ai, Weiyun Z.
Ambinder, Richard F.
Aoun, Patricia
Armand, Philippe
Bello, Celeste M.
Benitez, Cecil M.
Bierman, Philip J.
Chen, Robert
Dabaja, Bouthaina
Dean, Robert
Forero, Andres
Gordon, Leo I.
Hernandez-Ilizaliturri, Francisco J.
Hochberg, Ephraim P.
Huang, Jiayi
Johnston, Patrick B.
Kaminski, Mark S.
Kenkre, Vaishalee P.
Khan, Nadia
Maddocks, Kami
Maloney, David G.
Metzger, Monika
Moore, Joseph O.
Morgan, David
Moskowitz, Craig H.
Mulroney, Carolyn
Rabinovitch, Rachel
Seropian, Stuart
Tao, Randa
Winter, Jane N.
Yahalom, Joachim
Burns, Jennifer L.
Ogba, Ndiya
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (03): : 245 - 254
[4] Gastrointestinal Stromal Tumors Version 2.2022 Featured Updates to the NCCN Guidelines
von Mehren, Margaret
Kane, John M.
Riedel, Richard F.
Sicklick, Jason K.
Pollack, Seth M.
Agulnik, Mark
Bui, Marilyn M.
Carr-Ascher, Janai
Choy, Edwin
Connelly, Mary
Dry, Sarah
Ganjoo, Kristen N.
Gonzalez, Ricardo J.
Holder, Ashley
Homsi, Jade
Keedy, Vicki
Kelly, Ciara M.
Kim, Edward
Liebner, David
McCarter, Martin
McGarry, Sean, V
Mesko, Nathan W.
Meyer, Christian
Pappo, Alberto S.
Parkes, Amanda M.
Petersen, Ivy A.
Poppe, Matthew
Schuetze, Scott
Shabason, Jacob
Spraker, Matthew B.
Zimel, Melissa
Bergman, Mary Anne
Sundar, Hema
Hang, Lisa E.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (11): : 1204 - 1214
[5] Central Nervous System Cancers, Version 2.2022 Featured Updates to the NCCN Guidelines
Horbinski, Craig
Nabors, Louis Burt
Portnow, Jana
Baehring, Joachim
Bhatia, Ankush
Bloch, Orin
Brem, Steven
Butowski, Nicholas
Cannon, Donald M.
Chao, Samuel
Chheda, Milan G.
Fabiano, Andrew J.
Forsyth, Peter
Gigilio, Pierre
Hattangadi-Gluth, Jona
Holdhoff, Matthias
Junck, Larry
Kaley, Thomas
Merrell, Ryan
Mrugala, Maciej M.
Nagpal, Seema
Nedzi, Lucien A.
Nevel, Kathryn
Nghiemphu, Phioanh L.
Parney, Ian
Patel, Toral R.
Peters, Katherine
Puduvalli, Vinay K.
Rockhill, Jason
Rusthoven, Chad
Shonka, Nicole
Swinnen, Lode J.
Weiss, Stephanie
Wen, Patrick Yung
Willmarth, Nicole E.
Bergman, Mary Anne
Darlow, Susan
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01): : 12 - 20
[6] NCCN Guidelines® Insights Antiemesis, Version 2.2017 Featured Updates to the NCCN Guidelines
Berger, Michael J.
Ettinger, David S.
Aston, Jonathan
Barbour, Sally
Bergsbaken, Jason
Bierman, Philip J.
Brandt, Debra
Dolan, Dawn E.
Ellis, Georgiana
Kim, Eun Jeong
Kirkegaard, Steve
Kloth, Dwight D.
Lagman, Ruth
Lim, Dean
Loprinzi, Charles
Ma, Cynthia X.
Maurer, Victoria
Michaud, Laura Boehnke
Nabell, Lisle M.
Noonan, Kim
Roeland, Eric
Rugo, Hope S.
Schwartzberg, Lee S.
Scullion, Bridget
Timoney, John
Todaro, Barbara
Urba, Susan G.
Shead, Dorothy A.
Hughes, Miranda
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (07): : 883 - 893
[7] NCCN Guidelines® Insights Melanoma, Version 3.2016 Featured Updates to the NCCN Guidelines
Coit, Daniel G.
Thompson, John A.
Algazi, Alain
Andtbacka, Robert
Bichakjian, Christopher K.
Carson, William E., III
Daniels, Gregory A.
DiMaio, Dominick
Fields, Ryan C.
Fleming, Martin D.
Gastman, Brian
Gonzalez, Rene
Guild, Valerie
Johnson, Douglas
Joseph, Richard W.
Lange, Julie R.
Martini, Mary C.
Materin, Miguel A.
Olszanski, Anthony J.
Ott, Patrick
Gupta, Aparna Priyanath
Ross, Merrick I.
Salama, April K.
Skitzki, Joseph
Swetter, Susan M.
Tanabe, Kenneth K.
Torres-Roca, Javier F.
Trisal, Vijay
Urist, Marshall M.
McMillian, Nicole
Engh, Anita
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (08): : 945 - 958
[8] NCCN Guidelines® Insights Survivorship, Version 1.2016 Featured Updates to the NCCN Guidelines
Denlinger, Crystal S.
Ligibel, Jennifer A.
Are, Madhuri
Baker, K. Scott
Broderick, Gregory
Demark-Wahnefried, Wendy
Friedman, Debra L.
Goldman, Mindy
Jones, Lee W.
King, Allison
Ku, Grace H.
Kvale, Elizabeth
Langbaum, Terry S.
McCabe, Mary S.
Melisko, Michelle
Montoya, Jose G.
Mooney, Kathi
Morgan, Mary Ann
Moslehi, Javid J.
O'Connor, Tracey
Overholser, Linda
Paskett, Electra D.
Peppercorn, Jeffrey
Rodriguez, M. Alma
Ruddy, Kathryn J.
Sanft, Tara
Silverman, Paula
Smith, Sophia
Syrjala, Karen L.
Urba, Susan G.
Wakabayashi, Mark T.
Zee, Phyllis
McMillian, Nicole R.
Freedman-Cass, Deborah A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (06): : 715 - 724
[9] Survivorship, Version 1.2021 Featured Updates to the NCCN Guidelines
Tevaarwerk, Amye
Denlinger, Crystal S.
Sanft, Tara
Ansbaugh, Shannon M.
Armenian, Saro
Baker, K. Scott
Broderick, Gregory
Day, Andrew
Demark-Wahnefried, Wendy
Dickinson, Kristin
Friedman, Debra L.
Ganz, Patricia
Goldman, Mindy
Henry, Norah Lynn
Hill-Kayser, Christine
Hudson, Melissa
Khakpour, Nazanin
Koura, Divya
McDonough, Allison L.
Melisko, Michelle
Mooney, Kathi
Moore, Halle C. F.
Moryl, Natalie
Moslehi, Javid J.
O'Connor, Tracey
Overholser, Linda
Paskett, Electra D.
Patel, Chirayu
Peterson, Lindsay
Pirl, William
Rodriguez, M. Alma
Ruddy, Kathryn J.
Schapira, Lidia
Shockney, Lillie
Smith, Sophia
Syrjala, Karen L.
Zee, Phyllis
McMillian, Nicole R.
Freedman-Cass, Deborah A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (06): : 676 - 685
[10] Non-Hodgkin's Lymphomas, Version 3.2016 Featured Updates to the NCCN Guidelines
Horwitz, Steven M.
Zelenetz, Andrew D.
Gordon, Leo I.
Wierda, William G.
Abramson, Jeremy S.
Advani, Ranjana H.
Andreadis, C. Babis
Bartlett, Nancy
Byrd, John C.
Fayad, Luis E.
Fisher, Richard I.
Glenn, Martha J.
Habermann, Thomas M.
Harris, Nancy Lee
Hernandez-Ilizaliturri, Francisco
Hoppe, Richard T.
Kaminski, Mark S.
Kelsey, Christopher R.
Kim, Youn H.
Krivacic, Susan
LaCasce, Ann S.
Lunning, Matthew
Nademanee, Auayporn
Press, Oliver
Rabinovitch, Rachel
Reddy, Nishitha
Reid, Erin
Roberts, Kenneth
Saad, Ayman A.
Sokol, Lubomir
Swinnen, Lode J.
Vose, Julie M.
Yahalom, Joachim
Zafar, Nadeem
Dwyer, Mary
Sundar, Hema
Porcu, Pierluigi
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (09): : 1067 - 1079

← 1 2 3 4 5 →